menu search

Cenovus: the best oil stock for 2022

Cenovus is my largest position and I believe it is the best way to play a strong crude environment in 2...

December 27, 2021, 1:27 pm

Astrazeneca's covid-19 antibody effective against omicron variant

New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody Evus...

December 16, 2021, 1:27 pm

Astrazeneca's covid-19 antibody effective against omicron variant

New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody Evus...

December 16, 2021, 1:27 pm

Astrazeneca's covid-19 antibody effective against omicron variant

New preclinical data released by AstraZeneca Plc (NASDAQ: AZN) shows that its long-acting antibody Evus...

December 16, 2021, 1:27 pm

British american tobacco: vuse dividend insurance

BTI is clearly undervalued given its earnings growth and low share price. BTI has been burned by currency fluctuations which is hiding growth....

November 28, 2021, 10:18 am

British american tobacco: vuse dividend insurance

BTI is clearly undervalued given its earnings growth and low share price. BTI has been burned by currency fluctuations which is hiding growth....

November 28, 2021, 10:18 am

British american tobacco: vuse dividend insurance

BTI is clearly undervalued given its earnings growth and low share price. BTI has been burned by currency fluctuations which is hiding growth....

November 28, 2021, 10:18 am

Cenovus energy: bigger, better and stronger

Operational excellence and execution....

October 7, 2021, 12:26 pm

Cenovus energy: bigger, better and stronger

Operational excellence and execution....

October 7, 2021, 12:26 pm

Cenovus energy: bigger, better and stronger

Operational excellence and execution....

October 7, 2021, 12:26 pm

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREvus® (ocrelizu...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...

October 5, 2021, 1:00 am

Genentech to present new data on ocrevus (ocrelizumab) in multiple sclerosis and enspryng (satralizumab-mwge) in neuromyelitis optica spectrum disorder at ectrims 2021

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocre...

October 5, 2021, 1:00 am


Search within

Pages Search Results: